Aktuellt
SENASTE
Redeye retains its Base Case following Proact’s delayed deliveries. While Q4 2021, and possibly the next few quarters, will see an adverse effect from delays, we believe management seeing solid order intake during Q4 offsets the negative effect – leaving our organic, delay adjusted, 2022 forecasts largely unchanged.
LÄS MER
